| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | 
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Total Revenue | 135.69M | 149.74M | 203.48M | 279.19M | 344.61M | 275.97M | 
| Gross Profit | 25.32M | 18.37M | 22.52M | 65.10M | 95.61M | 84.90M | 
| EBITDA | -30.53M | -40.37M | -53.45M | -17.98M | -7.65M | -9.08M | 
| Net Income | -47.36M | -59.83M | -79.47M | -40.01M | -25.18M | -25.11M | 
| Balance Sheet | ||||||
| Total Assets | 159.07M | 206.14M | 254.19M | 356.60M | 457.13M | 398.43M | 
| Cash, Cash Equivalents and Short-Term Investments | 11.84M | 24.43M | 37.29M | 68.97M | 125.50M | 104.43M | 
| Total Debt | 116.09M | 143.05M | 111.44M | 123.28M | 114.31M | 87.25M | 
| Total Liabilities | 182.46M | 196.81M | 177.41M | 200.52M | 251.25M | 182.31M | 
| Stockholders Equity | -21.42M | 11.20M | 77.85M | 156.85M | 206.01M | 216.99M | 
| Cash Flow | ||||||
| Free Cash Flow | -25.33M | -46.02M | -23.85M | -74.46M | -6.00M | -13.09M | 
| Operating Cash Flow | -25.54M | -44.22M | -19.60M | -69.70M | 6.58M | 957.00K | 
| Investing Cash Flow | 526.00K | -1.31M | -2.36M | 60.61M | -69.13M | -16.34M | 
| Financing Cash Flow | 21.92M | 32.68M | -9.86M | 14.66M | 21.51M | -1.40M | 
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth | 
|---|---|---|---|---|---|---|---|
| ― | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
| ― | €444.45M | -25.97 | -23.45% | ― | 29.21% | -137.50% | |
| ― | HK$269.75M | -8.60 | -8.35% | 3.93% | 2.22% | -434.25% | |
| ― | HK$65.47M | ― | -52.67% | ― | -1.15% | -10025.00% | |
| ― | HK$1.44B | ― | -1.60% | ― | 32.83% | 90.24% | |
| ― | HK$486.21M | -13.98 | -31.98% | ― | -33.08% | -2532.02% | |
| ― | $53.93M | ― | -948.40% | ― | -20.25% | 46.77% | 
Jolimark Holdings Limited reported its unaudited consolidated results for the six months ending June 30, 2025, showing a decrease in revenue to RMB 70,195,000 from RMB 84,237,000 in the same period of 2024. Despite a reduction in operating loss from RMB 38,530,000 to RMB 28,705,000, the company still faced a net loss of RMB 31,000,000, reflecting ongoing challenges in managing costs and improving profitability.
Jolimark Holdings Limited has updated its profit warning for the six months ended 30 June 2025, indicating a reduced expected loss of between RMB30 million and RMB35 million, compared to the earlier estimate of RMB35 million to RMB40 million. This adjustment is primarily due to a decrease in the provision for asset impairment. The company is in the process of finalizing its financial results, which are anticipated to be released on 27 August 2025. Stakeholders are advised to exercise caution when dealing in the company’s securities.
Jolimark Holdings Limited has issued a profit warning, indicating an expected loss between RMB35 million and RMB40 million for the first half of 2025, primarily due to decreased printer demand and asset impairment provisions, with medical products not yet achieving significant sales. Following a temporary halt, trading of the company’s shares on the Hong Kong Stock Exchange is set to resume, reflecting the company’s ongoing efforts to stabilize its market position amid these financial challenges.
Jolimark Holdings Limited, a company listed on the Hong Kong Stock Exchange, has announced a trading halt of its shares effective from 1:00 p.m. on 12 August 2025. This halt is pending the release of an announcement containing inside information, indicating potential significant developments that could impact the company’s operations or market perception.
Jolimark Holdings Limited has announced that its board of directors will meet on August 27, 2025, to review and approve the interim financial results for the first half of the year ending June 30, 2025. The meeting will also consider the recommendation of an interim dividend, which could impact shareholder returns and reflect the company’s financial health.